Błażowska, O.; Stróżna, K.; Dancewicz, H.; Zygmunciak, P.; Zgliczyński, W.; Mrozikiewicz-Rakowska, B.
The Double-Edged Sword of Immunotherapy—Durvalumab-Induced Polyendocrinopathy—Case Report. J. Clin. Med. 2024, 13, 6322.
https://doi.org/10.3390/jcm13216322
AMA Style
Błażowska O, Stróżna K, Dancewicz H, Zygmunciak P, Zgliczyński W, Mrozikiewicz-Rakowska B.
The Double-Edged Sword of Immunotherapy—Durvalumab-Induced Polyendocrinopathy—Case Report. Journal of Clinical Medicine. 2024; 13(21):6322.
https://doi.org/10.3390/jcm13216322
Chicago/Turabian Style
Błażowska, Olga, Katarzyna Stróżna, Hanna Dancewicz, Przemysław Zygmunciak, Wojciech Zgliczyński, and Beata Mrozikiewicz-Rakowska.
2024. "The Double-Edged Sword of Immunotherapy—Durvalumab-Induced Polyendocrinopathy—Case Report" Journal of Clinical Medicine 13, no. 21: 6322.
https://doi.org/10.3390/jcm13216322
APA Style
Błażowska, O., Stróżna, K., Dancewicz, H., Zygmunciak, P., Zgliczyński, W., & Mrozikiewicz-Rakowska, B.
(2024). The Double-Edged Sword of Immunotherapy—Durvalumab-Induced Polyendocrinopathy—Case Report. Journal of Clinical Medicine, 13(21), 6322.
https://doi.org/10.3390/jcm13216322
